Scientists accidentally found a cure for cancer

In the lab, researchers have created a parasite protein combined with toxins to find cancer cells before they divide and develop disease.

Scientists have found a way to cure cancer

Scientists have discovered that the protein from malaria parasites can kill 9 of 10 most dangerous cancers today. A group of Danish and Canadian researchers accidentally discovered this breakthrough while seeking antimalarial drugs in pregnant women. The results of two research groups after testing thousands of samples from brain tumors to leukemia have shown that malaria parasite protein is capable of attacking more than 90% of all tumors.

Researcher on malaria, Professor Ali Salanti from the University of Copenhagen's Department of Immunology and Microbiology, said that the carbohydrate molecules from the malaria parasite in the placenta are identical to the carbohydrates found. in cancer cells. Mads Daugaard, head of the molecular pathology laboratory at Vancouver Cancer Center in Canada, said: "We have created proteins that malaria parasites use to attach to the placenta, in addition to When this complex is absorbed by cancer cells, the toxin is released, resulting in cancer cells being destroyed .All tests are conducted on mice infected with many types. Different cancers ".

Proteins from malaria parasites can kill 9 of 10 most dangerous cancers today.

With non-Hodgkin's lymphoma, the tumor in the rat's body is treated with a vaccine about the size of a quarter of the size of the tumor in the group of mice without the drug. With prostate cancer, tumors disappeared in two of the six mice treated a month after receiving the first doses. For metastatic bone cancer, five of the six treated mice remained alive for nearly eight weeks, compared with the number of none surviving among untreated mice.

Earlier, Professor Ali Salanti said: "For decades, scientists have been looking for similarities between placental development and a tumor. The placenta is an organ, within a few months. can grow only from a few cells to an organ weighing up to 0.9 kg, providing the embryo with oxygen and nourishing it as in external conditions, and the tumor also performs the same process and they grow strongly with the same conditions ".

During the study, a biotech company was formed through a partnership from two sides - the pharmaceutical company VAR2. Currently, the company has embarked on a large-scale clinical trial before it can be tested on humans. However, the biggest obstacle now is that in the placental cells of pregnant women, there are other cells that can participate in this study. Professor Ali Salanti said the trial period will last at least 4 years before everything is really smooth.